Lmr Partners LLP Tricida, Inc. Transaction History

Lmr Partners LLP

  • $10.5 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$7.31 - $11.85 $251,822 - $408,220
-34,449 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$7.35 - $10.63 $253,200 - $366,192
34,449 New
34,449 $283,000
Q3 2021

Nov 15, 2021
SELL
$3.56 - $4.64 $47,380 - $61,753
-13,309 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$3.95 - $5.41 $52,570 - $72,001
13,309 New
13,309 $57,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email